Stent-based nitric oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model

Cardiovasc Intervent Radiol. 2005 Jan-Feb;28(1):60-5. doi: 10.1007/s00270-004-0206-2.

Abstract

Background: The effects of nitric acid (NO) on vessel response to injury include the inhibition of platelet adhesion, platelet aggregation, leukocyte adhesion and smooth muscle cell proliferation. Releasing NO from a stent might reduce the clinical problem of restenosis. The present study was designed to examine whether an NO-eluting covered stent can prevent neointimal formation in a porcine carotid overstretch injury model.

Methods: The interior of a self-expanding polytetrafluoroethylene (ePTFE)-covered aSpire stent was coated with silicone, which contained 23.6 microg or 54.5 microg sodium nitroprusside (SNP, NO-releasing compound). The stent was implanted into carotid artery. Six pigs were implanted with stents, one high-dose SNP and one uncoated control, following balloon overstretch injury of the carotid artery with a balloon-to-artery ratio of 1.3:1.

Results: No local or systemic toxicity was evidenced in the six pigs after carotid artery implantation with either low- or high-dose stents within a week. At day 28, the mean intimal thickness was 0.12 +/- 0.05 mm for NO-eluting stents and 0.43 +/- 0.09 mm for uncoated stents (p = 0.008). The mean neointimal area was reduced from 2.40 +/- 0.39 mm2 for control stents to 0.49 +/- 0.16 mm2 for NO-eluting stents (p < 0.0001), which resulted in a 24% reduction of angiographic vessel narrowing.

Conclusions: The NO-eluting ePTFE-covered stent is feasible and effectively reduces in-stent neointimal hyperplasia at 28 days in a porcine carotid overstretch model.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Carotid Artery Injuries / pathology*
  • Carotid Stenosis / etiology
  • Carotid Stenosis / prevention & control*
  • Coated Materials, Biocompatible
  • Disease Models, Animal
  • Hyperplasia / pathology
  • Hyperplasia / prevention & control
  • Nitric Oxide / administration & dosage*
  • Nitric Oxide / pharmacology*
  • Polytetrafluoroethylene
  • Silicones
  • Stents*
  • Swine
  • Tunica Intima / drug effects
  • Tunica Intima / pathology

Substances

  • Coated Materials, Biocompatible
  • Silicones
  • Nitric Oxide
  • Polytetrafluoroethylene